September 29, 2011
AstraZeneca Pharmaceuticals Inc. announced Thursday that it had reached a settlement with rival Handa Pharmaceuticals LLC in several suits in New Jersey over Handa's bid to produce a generic version of the schizophrenia drug Seroquel XR.
March 10, 2011
AstraZeneca Pharmaceuticals Inc. moved Wednesday to block a rival from using one of its paid consultants as an expert witness in ongoing patent infringement litigation in New Jersey over a proposed generic version of schizophrenia treatment Seroquel XR.